Key result
TEC4Home telemonitoring linked to ~56% lower health system costs vs usual care over 90 days.
Why the study?
Heart failure is a costly condition with increasing prevalence in older adults, and home telemonitoring aims to improve care during transition from emergency to home but its cost impact is unclear.
Does home telemonitoring (TEC4Home) reduce health care costs in patients with heart failure transitioning from the emergency department to home?
Does home telemonitoring (TEC4Home) reduce health care costs in patients with heart failure transitioning from the emergency department to home?
Absolute Event Rate: 1293% vs 2924%
p-value: p=0.01
Home telemonitoring for heart failure patients transitioning from the emergency department to home is associated with significant cost savings from both health system and societal perspectives over 90 days.
Home telemonitoring demonstrates high feasibility and adherence post-HF discharge; hypothesis-generating for outcome benefits pending RCT confirmation.
BACKGROUND: Heart failure (HF) is a costly health condition and a major public health problem. It is estimated that 2%-3% of the population in developed countries has HF, and the prevalence increases to 8% among patients aged ≥75 years. Home telemonitoring is a form of noninvasive, remote patient monitoring that aims to improve the care and management of patients with chronic HF. Telehealth for Emergency-Community Continuity of Care Connectivity via Home-Telemonitoring (TEC4Home) is a project that implements and evaluates a comprehensive home monitoring protocol designed to support patients with HF as they transition from the emergency department to home. OBJECTIVE: The aim of this study is to assess the cost of using the home monitoring platform (TEC4Home) relative to usual care for patients with HF. METHODS: This study is a cost-consequence analysis of the TEC4Home pilot study. The analysis was conducted from a partial societal perspective, including direct and indirect health care costs. The aim is to assess the costs of the home monitoring platform relative to usual care and track costs related to health care utilization during the 90-day postdischarge period. RESULTS: Economic analysis of the TEC4Home pilot study showed a positive trend in cost savings for patients using TEC4Home. From both the health system perspective (Pre TEC4Home cost per patient: CAD $2924 vs post TEC4Home cost per patient: CAD $1293; P=.01) and partial societal perspective (Pre TEC4Home cost per patient: CAD $2411 vs post TEC4Home cost per patient: CAD $1108; P=.01), we observed a statistically significant cost saving per patient. CONCLUSIONS: In line with the advantages of conducting an economic analysis alongside a feasibility study, the economic analysis of the TEC4Home pilot study facilitated the piloting of patient questionnaires and informed the methodology for a full clinical trial.
No takes yet. Share an insight, caveat, or question.
Apantaku et al. (2022) studied Heart failure. TEC4Home home telemonitoring vs. Usual care (Pre TEC4Home) was evaluated on Cost per patient from the health system perspective (p=0.01). The TEC4Home home telemonitoring platform significantly reduced health system costs per patient compared to the pre-implementation period (CAD $1293 vs CAD $2924; P=0.01) over 90 days postdischarge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: